Solanezumab
Solanezumab (proposed INN, LY2062430) is a monoclonal antibody being investigated by Eli Lilly as a neuroprotector for patients with Alzheimer's disease. The drug originally attracted extensive media coverage proclaiming it a breakthrough, but it has failed to show promise in Phase III trials.
-
- Type: Rabbit IgG
- Application: CyTOF, FC, WB
Compare
-
- Type: Rabbit IgG
- Application: FC
Compare
-
- Type: Rabbit IgG
- Application: FC
Compare
-
- Type: Rabbit IgG
- Application: FC
Compare
-
- Type: Rabbit IgG
- Application: FC
Compare
-
- Type: Rabbit IgG
- Application: FC
Compare
-
- Type: Rabbit IgG
- Application: FC
Compare
-
- Type: Rabbit IgG
- Application: FC
Compare
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
For Research Use Only. Not For Clinical Use.